Is Biocept Inc (BIOC) a Bad Choice in Diagnostics & Research Friday?

Friday, October 15, 2021 02:01 PM | InvestorsObserver Analysts

Mentioned in this article

Is Biocept Inc (BIOC) a Bad Choice in Diagnostics & Research Friday?

Biocept Inc (BIOC) is around the top of the Diagnostics & Research industry according to InvestorsObserver. BIOC received an overall rating of 56, which means that it scores higher than 56 percent of all stocks. Biocept Inc also achieved a score of 73 in the Diagnostics & Research industry, putting it above 73 percent of Diagnostics & Research stocks. Diagnostics & Research is ranked 58 out of the 148 industries.

BIOC has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on BIOC!

See Full BIOC Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 56 would rank higher than 56 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Biocept Inc Stock Today?

Biocept Inc (BIOC) stock has fallen -3.44% while the S&P 500 is higher by 0.71% as of 1:51 PM on Friday, Oct 15. BIOC is lower by -$0.14 from the previous closing price of $4.05 on volume of 152,861 shares. Over the past year the S&P 500 has gained 28.32% while BIOC is lower by -17.86%. BIOC lost -$0.12 per share the over the last 12 months. Click Here to get the full Stock Report for Biocept Inc stock.